[ad_1]
The results of an artificial pancreas pancreas system based on Korean pancreas for the treatment of type 2 diabetes mellitus helped the New England Journal of Medicine (NEJM) (19459009)] Professor Emeritus and Soil Development Co., Ltd. (Representative Yoon Yun-hee) is the head of the Ambbadador's Research Center in Cambridge, England. A team of professors has announced the results of a clinical study on the excellent glycemic control of the artificial pancreas (insulin pump + continuous glucometer) of the danadaiabe care system in patients with type 2 diabetes in a recent issue. from NEJM
The Dana Daiabe Care System artificial pancreas is a medical device that continuously measures blood glucose and automatically injects insulin accordingly.
The research team conducted a total of 136 patients with type 2 diabetes who were studying the source technology developed by Professor Choi, Soil Development Co., Ltd. for industrialization and refractory diabetic domestic and foreign patients. 70 patients were treated with closed loop (A) and 66 patients with clbadical insulin infusion therapy (B), respectively.
As a result, the ratio of time in target blood glucose (100-180mg / ㎗ ) was 65.8% in group A and 41.5% in group B , As well. Two-thirds of the new treatment group A was in the target blood glucose range (65.8%), but only about two-fifths of the existing treatment group B was in the target blood glucose range (41.5%). %)
Mean blood glucose was also significantly different between group A (154 mg / dl) and group B (188 mg / dl). However, there was no difference in the frequency of hypoglycemia in both groups of patients.
"Closed Loop" means that when the blood sugar level is high, the pancreas manufactures more insulin hormones and reduces blood sugar. It's like a closed circuit that automatically adjusts the blood sugar so that it does not secrete.
Professor Choi said: "Until now, insulin pump + continuous loop studies have shown that type 1 (insulin pump + continuous glucometer) It is known that diabetes mellitus (diabetes mellitus) type 2) provides limited glycemic control only for very specific patients, for example, in the treatment of patients in the intensive care unit.
However, in the case of patients with type 2 diabetes, the insulin pump + closed loop and artificial pancreas were more effective than the control of blood glucose for insulin injections.
In the future, treatment guidelines for diabetic patients who need control of the blood sugar levels are likely to change. "
NEJM publishers also commented on the study of the effect of the artificial pancreas," In the near future, on the other hand, Soil Development Co., Ltd. , develops spouse the communication protocol of the insulin pump with Professor Horborka during this month, "
Ki-Soo Soo, Medical Journalist, [email protected]
[ad_2]
Source link
